Get started

Shortsqueeze

KALA Levels + Short InfoShort squeeze stocks have become a favorite recently. KALA has started getting wrapped into the conversation. Looking at details from sites like FinViz, short float is around 20% meanwhile the float itself shows to be around 42 million shares. Plotting some levels, you'll notice that KALA is still in the lower channel on the fib retracement slowly heading toward the 786 area. However, before that happens, keep watch on an interim level around $3.40. It was previously a support level in July but seems to have become a resistance level as KALA was strongly rejected right at $3.40 on Friday. Aside from the technical/speculative trend, there are also a few things to watch with the company after a rough first half: " Kala specializes in eye treatments. Its EYSUVIS is quickly playing a leading role for the company. According to the company, this past quarter, it was a preferred prescription for short-term treatment of dry eye disease. Furthermore, Kala explained that its expanding market access with Commercial and Medicare Part D health plans...Mark Iwicki, Chairman, President, and Chief Executive Officer of Kala Pharmaceuticals, explained, “We are encouraged by the very positive feedback we consistently receive from physicians and patients, who describe EYSUVIS as an effective and comfortable medicine and look forward to building on this foundation as we continue with the EYSUVIS launch. In parallel, we continue to promote INVELTYS and are advancing our pipeline of new chemical entities for front and back of the eye diseases, as we work to build a robust and sustainable portfolio of innovative treatments.” " Quote Source & Read More: 4 Short Squeeze Penny Stocks To Watch After SPRT Stock’s 1,309% Run
NASDAQ:KALA
by PennyStocks101
CLVS back on the low lowCLVS is now back at its November 2020 low. The interesting part of this trend is that it also managed to test, hold, and bounce off of an almost identical level (strong support?). As of Friday afternoon shares retested an interim area of higher traffic that was support earlier in August and late July but now appears to have become a resistance level over the last 3 sessions at least. With the "short squeeze stocks" conversation building steam, it could be interesting for CLVS. Finviz shows the short float percentage at 27% right now. " The biotech sector may also host some of the other heavily shorted stocks. Phase trial data, scientific reports, and the like all play a role in directional momentum. In this case, Clovis has felt some pressure over the last few quarters. Clinical data on its FAP-2286 platform, along with missed earings, haven’t helped the cause. Then you’ve got news of large, multi-million dollar fundraising initiatives adding more pressure as well. Needless to say, it has happened to hopefully advance the company’s pipeline...Clovis specializes in developing cancer treatments. Its lead candidate Rubraca is an oral treatment being developed in multiple types of tumors. These include ovarian and prostate cancers. It’s approved in the US for maintenance treatment in adults with recurrent epithelial, ovarian, fallopian tube, or primary peritoneal cancers...As far as CLVS being considered one of the “short squeeze stocks,” outlets show that the penny stock’s short-interest sits around 27%. Of course, it isn’t as high as some of the others on this list. However, anything over 20%, by most accounts, can be considered high. " Quote Source & Read More: 4 Short Squeeze Penny Stocks To Watch After SPRT Stock’s 1,309% Run
C
by PennyStocks101
ATER Trying To Redeem ItselfWe've looked at countless charts and share structures of the so called "short squeeze stocks" with ATER popping up. While it isn't the highest short interest, sites like finviz point out a short float percentage of over 20%. Further, the penny stock fell hard in August after filing a registration statement for selling shareholders at 2.7 million shares. Thanks to the likes of SPRT BBIG and even MMAT , these high-short interest stocks are the talk of the market right now. The big question is will they hold up to the hype and how long will the moves last IF they even begin in the first place? " While no news was announced sparking this gain, we did see many tech penny stocks climb during today’s session. However, it did report its second quarter 2021 financial results only a few weeks ago. In the results, the company reported 14% growth in its revenue YoY to $68.2 million. In addition, it managed to grow its gross margin from 46.7% to 48% in addition to decreasing its operating expenses from $29.4 million to $28.4 million...“This has been a challenging quarter for e-commerce marked by a global supply chain crisis, inflation and an extreme shift in consumer behavior due to the opening of brick and mortar stores after the relaxation of COVID-19 related restrictions...Despite the difficult environment and significant increase in product variable cost, our sales grew on average 20% on a proforma basis across all fourteen brands compared to the second quarter of 2019.” The Co-Founder and CEO of Aterian Inc., Yaniv Sarig " Quote Source & Read More: These 3 Penny Stocks Exploded on Friday, Here’s Why
NASDAQ:ATER
by PennyStocks101
Will These Levels MMAT er This Week?MMAT has been on the list of short squeeze stocks recently. SPRT 's big move along with BBIG 's big pop helped spotlight some stocks with higher short interest. For this retracement, we didn't do much more than extend out the same fib retracement we plotted in July, which still appears to show relevancy. What's more, is MMAT has a few other things to keep in mind outside of the typical technical/speculative trends: " The company recorded 197% revenue growth in the second quarter as it continues seeking new contracts. This comes as Meta Materials works to button up yet another acquisition. This one is for Nanotech Security Corp., valued at just under C$91 million. The deal is expected to expand and speed up Meta’s commercialization strategy. In particular, it brings Nanotech’s electron beam lithography equipment anticipated to decrease production costs noticeably. “Nanotech also adds complementary skillsets which can support META’s markets, accelerating our commercialization plans in verticals such as solar energy, 5G and other antennas, battery and fuel cells, and carbon capture,” said George Palikaras, META’s President and CEO...As it relates to MMAT stock short interest, outlets are showing a short float as of today’s date above 40%. However, it does make sense that some have taken bearish bets on the company considering all of the cash laid out for its current and pending acquisitions. Needless to say, it has been one of the penny stocks to watch this week. " Quote Source & Read More: 4 Short Squeeze Penny Stocks To Watch After SPRT Stock’s 1,309% Run
M
by PennyStocks101
AMC Short Squeeze Prediction (Third Times A Charm)When looking at AMC's price action in the previous months, September, particularly the week of 6th-10th, is looking real bullish for AMC. The first squeeze attempt happened Wednesday January 27th, the second Wednesday June 2nd. Both occurred in weeks where Monday landed on a holiday. Is it a coincidence that AMC's price action is rising and that September 6th happens to also be a holiday? Take this with a grain of salt because AMC is a hard one to predict, but September 8th looks really good on my calendar.
NYSE:AMCLong
by TradingWithEmotion
3
AMC Start of a New Run?30 Minute Chart As you can see, previously we dipped down 17% from $39 to $32. Then we went from $32 all the way to our current highs of $48 around a 50% gain. We have now seen a drop of around 17% from $48 to $40. MACD is also showing signs of crossover to upside. RSI showing a similar trend which we have hit the 30 level on RSI. In both RSI patterns we have seen a bounce back to the overbought region (+70 RSI). if we continue this pattern we could see another similar run up around 50% which would make for a 20 pt move from $40 to $60. Please let me know what you guys think ! All comments welcome. Leave a like if you enjoyed this setup.
NYSE:AMCLong
by Smarter_Trades
5
$Aso, High probability short squeeze by swing tradingThe stock is holding at the area of 42.69. it's no right time for an entry, as the stock is extended from it's 5 & 10 period moving average where we expect the price to consolidate or pull back producing a right entry at the are of 42.69, the stock is highly correlated with the General market and should be traded with high caution. stock can be traded in daily, hourly or any other intraday time frame as per your style of trading. if anything, please do drop a comment below. thank you. Real time trade with educational purpose, please don't forget to do your homework.
NASDAQ:ASOLong
by localogist
There's a riot coming... Short Squeeze on RIOTWith a Short Interest of 26% and an active attempt to squeeze the shorts it looks like RIOT could see a volatile move upwards supported by reasonable fundamentals, Bitcoins recent price action, and technical indicators that suggest a reversal. Setting up to break out of a descending channel/wedge. F-Score is a 5 with some indication the books may be cooked so this likely isn't a buy & hold. Price target & stop loss recommendation put this at a 6:1 risk to reward ratio. Timeline is days to weeks. Watch for a position Monday morning around 10:30am.
NASDAQ:RIOTLong
by jsgiardino
$ESPR Short squeeze - 1 D Candle I think ESPR could start to get interested in this level . - After a long decline from the peak ($ 40) this year, on 27/1/2021, we are now witnessing a consolidation in the price level. - I do not look at fundamental information, only technical data . Indicators : * EMA21 is the purple line * EMA9 is the green line * Consolidation at Slow Stochastic * RSI begins to change direction - 26.23M short float (low float) - Setup: Falling Wedge - Short floating percentage 32.48% - Above the consolidation at 15$ squeeze can happen * It can be very aggressive .. think of all the Short's sellers who will have to cover positions after they see a price level break after consolidation ... * No financial advice just my personal opinion, make your own DD!
NASDAQ:ESPRLong
by SaTLla101